The most important thing a woman starting a GLP-1 should know has nothing to do with weight: these medications can make your birth control less reliable and can restore fertility you weren't counting on — and they're not safe to take in pregnancy. "Ozempic babies" became a headline for a reason. Here are the women's-health angles worth understanding before and during treatment, from contraception to PCOS to bone health.
Birth control and "Ozempic babies": the interaction to know
Two separate things can lead to an unplanned pregnancy on a GLP-1, and they stack:
- The pill can absorb less well. Tirzepatide (Mounjaro, Zepbound) can reduce the absorption of oral contraceptives, because slowed stomach emptying affects how the pill is taken up — a mechanical effect, not a hormonal one. Its label advises women on the pill to either switch to a non-oral method (implant, IUD, injection) or add a barrier method like condoms for 4 weeks after starting and for 4 weeks after each dose increase. Semaglutide (Ozempic, Wegovy) does not carry this specific warning — but if you're unsure which applies to you, ask your prescriber.
- Fertility can come back. Weight loss can restore ovulation in women who weren't ovulating regularly — especially with PCOS. That's a good thing if you want to conceive and an easy surprise if you don't. Drug regulators have specifically urged women on weight-loss GLP-1s to use effective contraception for exactly this reason.
The takeaway: if you don't want to be pregnant, use a reliable, non-oral or backed-up method while you're on a GLP-1 — don't assume the pill alone has you covered.
If you're pregnant, or planning to be
GLP-1 medications are not recommended in pregnancy, while trying to conceive, or while breastfeeding — the safety data in humans are insufficient, and animal studies raised concerns. Because these drugs clear from the body slowly, the guidance is to stop before trying to conceive and allow a wash-out period rather than stopping only once you see a positive test. The exact timing depends on the specific medication (tirzepatide guidance is at least a month before a planned pregnancy; semaglutide, with its long half-life, is often stopped roughly two months ahead) — confirm the number for your drug with your prescriber. If you become pregnant unexpectedly while taking one, contact your prescriber promptly rather than waiting.
PCOS: often where GLP-1s help the most
Polycystic ovary syndrome — common, driven heavily by insulin resistance and excess weight, and a leading cause of irregular cycles and infertility in women — is one of the areas where these medications are most promising. GLP-1 receptor agonists are described as an attractive option for weight loss in PCOS, though the authors note that PCOS-specific data are still limited and there are real safety considerations around conception (Prentice & Rassie, Drug and Therapeutics Bulletin, 2026, DOI (external link), via PubMed). Beyond weight, they can improve insulin resistance and, in some women, help restore ovulation and more regular cycles (Nicolaou et al., Cureus, 2025, DOI (external link), via PubMed) — which loops right back to the contraception point above: better PCOS control can mean returning fertility.
Menopause and the body-composition shift
Menopause changes where the body stores fat and how easily it holds muscle — the same terrain a GLP-1 works on, which is why hormone therapy and these medications keep coming up together. They're different tools that can complement each other. If you're navigating this, our guides on HRT for women and GLP-1 medications and the HRT and GLP-1 overview cover how they intersect.
Bone and muscle: a bigger deal for women
Women carry a higher lifetime risk of osteoporosis, and rapid weight loss takes some bone and lean mass along with fat — a trade worth actively defending, especially around and after menopause when bone loss accelerates. The protections are practical: resistance training to preserve muscle and load bone (see why strength training matters on a GLP-1), enough protein despite a suppressed appetite (high-protein meals and snacks when your appetite is low), and adequate calcium and vitamin D (supplements on a GLP-1). Strength work plus protein shifts more of what you lose toward fat and away from muscle and bone.
The heart
Heart disease is underdiagnosed in women, partly because symptoms and risk get taken less seriously. GLP-1s pull in a helpful direction: in a large 2025 real-world study of adults with obesity, GLP-1 use was associated with lower rates of major adverse cardiovascular events and all-cause mortality than other weight-loss medications (Tang et al., Diabetes, Obesity & Metabolism, 2025, DOI (external link), via PubMed). As with everything here, the benefit depends on staying engaged with your care and your labs.
The mental and body-image load
Rapid body change lands emotionally, and for many women it interacts with a long history of weight talk, dieting, and how the world responds to their appearance. If your self-image is lagging behind the mirror, that's common — our guide on body-image lag versus body dysmorphia covers the difference and where to get help.
The bottom line
The weight-loss part of a GLP-1 works the same regardless of sex — but for women, fertility sits at the center of the picture in a way it doesn't for men. These medications can quietly return fertility and undercut the pill, and they're not for use in pregnancy, so contraception is the first conversation, not an afterthought. They also shine in PCOS, and they ask you to actively protect bone and muscle. None of it replaces your prescriber — but going in knowing which questions are yours to ask is what keeps a good result a safe one.
This article is general education, not medical advice. Contraception, pregnancy, and PCOS decisions are individual and time-sensitive — confirm the specifics for your medication with your prescriber. Do not start, stop, or change any medication based on this article alone. Research findings above are attributed to PubMed-indexed articles with DOI links.